Comparison between Saroja Pharma IPO and Sungarner Energies IPO.
Saroja Pharma IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sungarner Energies IPO is a SME Fixed Price proposed to list at NSE SME.
| Saroja Pharma IPO | Sungarner Energies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Novus Capital Advisors Private Limited |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Swastika Investmart Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Saroja Pharma IPO is up to ₹8.66 Cr whereas the issue size of the Sungarner Energies IPO is up to ₹4.83 Cr. The final issue price of Saroja Pharma IPO is ₹84.00 per share and of Sungarner Energies IPO is ₹83.00 per share.
| Saroja Pharma IPO | Sungarner Energies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹84.00 per share | ₹83.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 10,30,400 shares | 5,82,400 shares |
| Fresh Issue Size (Amount) | up to ₹8.66 Cr | up to ₹4.83 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 10,30,400 shares | 5,82,400 shares |
| Issue Size Total (Amount) | up to ₹8.66 Cr | up to ₹4.83 Cr |
Saroja Pharma IPO opens on Aug 31, 2023, while Sungarner Energies IPO opens on Aug 21, 2023. The closing date of Saroja Pharma IPO and Sungarner Energies IPO is Sep 05, 2023, and Aug 23, 2023, respectively.
| Saroja Pharma IPO | Sungarner Energies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 31, 2023 | Aug 21, 2023 |
| Issue Close | Sep 05, 2023 | Aug 23, 2023 |
| Basis Of Allotment (Tentative) | Sep 08, 2023 | Aug 28, 2023 |
| Initiation of Refunds (Tentative) | Sep 11, 2023 | Aug 29, 2023 |
| Credit of Share (Tentative) | Sep 12, 2023 | Aug 30, 2023 |
| Listing date (Tentative) | Sep 13, 2023 | Aug 31, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Saroja Pharma IPO P/E ratio is 23.25, as compared to Sungarner Energies IPO P/E ratio of 13.07.
| Saroja Pharma IPO | Sungarner Energies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Standalone)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 84.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.02 | 61.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 23.25 | 13.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹33.77 Cr. | ₹19.25 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15 | 31.17% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 25 | 25.28% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.00 | 1.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.61 | ₹6.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.85 | 23.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Saroja Pharma IPO Retail Individual Investors (RII) are offered 5,15,200 shares while in Sungarner Energies IPO retail investors are offered 5,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Saroja Pharma IPO and in Sungarner Energies IPO.
| Saroja Pharma IPO | Sungarner Energies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 54,400 shares | 57,600 shares |
| QIB | ||
| NII | 5,15,200 shares | 2,91,200 shares |
| RII | 5,15,200 shares | 2,91,200 shares |
| Employee | ||
| Others | ||
| Total | 10,30,400 shares | 5,82,400 shares |
Saroja Pharma IPO subscribed 8.88x in total, whereas Sungarner Energies IPO subscribed 152.40x.
| Saroja Pharma IPO | Sungarner Energies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.90x | 110.59x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 14.83x | 192.93x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.88x | 152.40x |
